| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |